Compliance with the vaccination schedule against Hepatitis A, B and A+B in international travellers

Section: Originals

How to quote

Crespo Alonso A, Pedraza Montero E, Villar Tojeiro B. Cumplimiento de las pautas de vacunación de hepatitis A, B y A+B en viajeros internacionales. Metas Enferm oct 2017; 20(8): 18-23.

Authors

Ana Crespo Alonso1, Elena Pedraza Montero1, Braulio Villar Tojeiro1

Position

1Enfermera/o. Sanidad Exterior. Centro de Vacunación Internacional de Vigo (Pontevedra)

Contact address

Elena Pedraza Montero. Rua Galicia, 2-portal C, 4º C. 36450 Salvaterra de Miño (Pontevedra).

Contact email: elena.pedraza.montero@hotmail.com

Abstract

Objective: to determine the compliance with the vaccination schedule against Hepatitis A (HA), Hepatitis B (HB) and Hepatitis A+B (HA+B), regarding the number of doses administered and the intervals between them, according to the recommendations in the product specifications.
Method: a descriptive cross-sectional study among those travellers who attended the International Vaccination Centre in Vigo
(IVC) between June, 1st, 2011 and November, 30th, 2013. Sociodemographical, travel and vaccination variables were collected.
Results: the total sample included 1,028 travellers, 62.9% were male, with 35.2 years as mean age. The total number of prescriptions for vaccination initiation was 1,117, distributed as follows: HA (58.9%), HA+B (15.9%), HA and HB (13.7%) and HB (11.6%). A 4.2% of travellers refused to be vaccinated. The overall compliance rate was 41.4%; and specifically, 38.5% for HA, 37.2% for HB and 55.7% for HA+B.
Conclusions: the majority of travellers accept vaccination, though it has been observed that there is poor compliance of its schedule, leading to different consequences for the health of travellers. The high rate of vaccination initiation does not coincide with its continuity, and therefore the IVC must implement measures in order to improve adherence, such as reminder systems for subsequent vaccine doses, probing into the reasons for non-compliance in order to eliminate barriers, and implementation of different vaccination schedules that will facilitate compliance and rapid immunization.

Keywords:

Travels; Travel Medicine; Vaccines; vaccination; immunization; viral hepatitis; treatment compliance; patient cooperation; cross-sectional studies

Versión en Español

Título:

Cumplimiento de las pautas de vacunación de hepatitis A, B y A+B en viajeros internacionales

Artículo completo no disponible en este idioma / Full article is not available in this language

Bibliography

  1. Zhang Zl, Zhu Xj, Shan Al, GaoZg, Zhang Y, Ding Yx, et al. Effectiveness of 10-year vaccination (2001–2010) on Hepatitis A in Tianjin, China. Hum Vaccin Immuno Ther. 2014; 10(4):1008-12.
  2. Noele N, Trudy M. Chapter 3: Hepatitis A. In: Centers for Disease Control and Prevention. CDC Health Information for International Travel 2016. New York: Oxford University Press; 2016. p. 114-21.
  3. Pedersini R, Marano C, De Moerlooze L, Chen L, Vietri J. HAV & HBV vaccination among travellers participating in the National Health and Wellness Survey in five European countries. Travel Med Infect Dis. 2016; 14(3):221-32.
  4. Jacobsen KH. The global prevalence of hepatitis A virus infection and susceptibility: a systematic review. Ginebra: WHO; 2009.
  5. Averhoff F. Chapter 3: Hepatitis B. In: Centers for Disease Control and Prevention. CDC Health Information for International Travel 2016. New York: Oxford University Press; 2016. p. 121-7.
  6. Kroger A, Strikas R. Chapter 2: General Recommendations for Vaccination & Immunoprophylaxis. In: Centers for Disease Control and Prevention. CDC Health Information for International Travel 2016. New York: Oxford University Press; 2016. p. 22-3.
  7. Organización Mundial de la Salud. Oficinas regionales de las OMS [internet]. Ginebra: OMS; 2013. [citado 15 sep 2017]. Disponible en: http://www.who.int/about/regions/es/
  8. López-Vélez R, Bayas JM. Spanish Travelers to High-Risk Areas in the Tropics: Airport Survey of Travel Health Knowledge, Attitudes, and Practices in Vaccination and Malaria Prevention. J Travel Med. 2007; 14(5):297-305.
  9. Wilder-Smith A, Khairullah N, Song J, Chen C, Torresi J. Travel health knowledge, attitudes and practices among Australasian travelers. J Travel Med. 2004; 11:9-15.
  10. Muller JM, Simonet AL, Binois R, Muggeo E, Bugnon P, Liet J, et al. The respect of recommendations provided in an international travelers’ medical service: far from the cup to the lips. J Travel Med. 2013; 20(2):78-82.
  11. Baón BS, Berbel C, Jiménez T, Morquecho M, Allúe E, Cantón MB. Cumplimiento de las recomendaciones de vacunación contra hepatitis A, fiebre tifoidea y tétanos-difteria en viajeros atendidos en un centro de vacunación internacional. Vacunas. 2015; 6:82-5.
  12. Garrido P, Ramón JM, Plans P, Ocaña A, Páramo P, Gajans M, et al. Vacunación incompleta en la población general. Vacunas. 2003; 4:41-8.
  13. Lu PJ, Byrd KK, Murphy TV. Hepatitis A vaccination coverage among adults 18-49 years traveling to a country of high or intermediate endemicity, United States. Vaccine.2013; 31(19):2348-57.
  14. Connor BA, Jacobs RJ, Meyerhoff AS. Hepatitis B risks and immunization coverage among American travelers. J Travel Med. 2006; 13(5):273-80.
  15. Picazo JJ. Principios generales. En: Picazo JJ. Guía práctica de vacunaciones 2006. Madrid: ICM; 2005. p. 25-129.
  16. Ott JJ, Wiersma ST. Single-dose administration of inactivated hepatitis A vaccination in the context of hepatitis A vaccine recommendations. Int J Infect Dis. 2013; 17(11):e939-e944.
  17. Jiseun L, Yeong-Jun S, Woong-Sub P, Haesook S, Moo-Sik L, Dong-Hoon S, et al. The Immunogenicity of a Single Dose of Hepatitis A Virus Vaccines (Havrix® and Epaxal®) in Korean Young Adults. Yonsei Med J [internet]. 2014 Jan [cited 15 sep 2017]; 55(1):126-131. Available from: https://www.eymj.org/DOIx.php?id=10.3349/ymj.2014.55.1.126
  18. Ibáñez-Jiménez A, Pairet-Jofre G, Prat-Gonzalez I, Sánchez Doblado MJ, Tauler-Suñer M. Ensayo clínico aleatorizado acerca de la efectividad del recordatorio postal para aumentar la cobertura vacunal contra tétanos-difteria en población adulta joven. Enferm Clin. 2007; 17(4):171-6.
  19. Vilella A, Bayas JM, Díaz MT, Guinovart C, Díez C, Simó D, et al. The role of mobile phones in improving vaccination rates in travelers. Prev Med [internet]. 2004 Apr [cited 15 sep 2017]; 38(4):503-9. Available from: https://www.ncbi.nlm.nih.gov/pubmed/15020186
  20. Wong J, Payne M, Hollenberg S. A double-dose hepatitis B vaccination schedule in travelers presenting for late consultation. J Travel Med. 2014; 21(4):260-5.